David R. Bauer
Lawyers
Filters
TBCASoft $25 million Series B equity funding round
We advised Naver Financial on its strategic investment in TBCASoft
Adagio Therapeutics $356 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Nurix Therapeutics $150 million at-the-market offering
We advised the sales agent on the stock offering
RxSight $117.6 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
Tenaya Therapeutics $207 million IPO
We advised the underwriters on the IPO and Nasdaq listing
SOPHiA GENETICS $234 million IPO and $20 million private placement
We advised SOPHiA GENETICS on its IPO, Nasdaq listing and concurrent private placement
TScan Therapeutics $100 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Acutus Medical $77 million follow-on offering
We advised Acutus Medical on the SEC-registered stock offering
Sight Sciences $276 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
IDEAYA Biosciences $92 million follow-on offering
We advised the underwriters on the SEC-registered stock offering